These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 8152446)
1. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. Poupon RE; Poupon R; Balkau B N Engl J Med; 1994 May; 330(19):1342-7. PubMed ID: 8152446 [TBL] [Abstract][Full Text] [Related]
2. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. Poupon RE; Balkau B; Eschwège E; Poupon R N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105 [TBL] [Abstract][Full Text] [Related]
3. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Lindor KD N Engl J Med; 1997 Mar; 336(10):691-5. PubMed ID: 9041099 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Combes B; Carithers RL; Maddrey WC; Lin D; McDonald MF; Wheeler DE; Eigenbrodt EH; Muñoz SJ; Rubin R; Garcia-Tsao G Hepatology; 1995 Sep; 22(3):759-66. PubMed ID: 7657280 [TBL] [Abstract][Full Text] [Related]
5. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499 [TBL] [Abstract][Full Text] [Related]
6. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis. Jorgensen R; Angulo P; Dickson ER; Lindor KD Am J Gastroenterol; 2002 Oct; 97(10):2647-50. PubMed ID: 12385454 [TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. Kaplan MM; Cheng S; Price LL; Bonis PA Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894 [TBL] [Abstract][Full Text] [Related]
8. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Bonnand AM; Heathcote EJ; Lindor KD; Poupon RE Hepatology; 1999 Jan; 29(1):39-43. PubMed ID: 9862847 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. Lee YM; Kaplan MM Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960 [TBL] [Abstract][Full Text] [Related]